East and West to form a pact for Covid vaccine catering to the US market
In the series of recent Covid related events, two bigshot Biotech firms from the east(India) and west (US) have decided to co-create the vaccines for corona.

We use cookies for a better user experience. Read our Privacy Policy
In the series of recent Covid related events, two bigshot Biotech firms from the east(India) and west (US) have decided to co-create the vaccines for corona.
The rise in adoption of AI-systems in the Automotive industry has backed up Hyundai India’s growth even more amidst the Lockdown period, giving it a ground-breaking record of the highest ever monthly production of 71,000 units in December 2020, pushing their existing capacity by 20%.
The global market for Automotive is going through its most significant transition ever. Automakers constantly develop various new techniques or modes of driving vehicles autonomously and electrically, and adjust their business models and product portfolios accordingly.
The experimental coronavirus vaccine of Gilead Sciences Inc. failed its first randomized clinical trial, announced on April 23, 2020, but the drugmaker said the findings of the test in China were inconclusive as it was completed early. Gilead's stock dropped almost 6% to $76.56, which comes days after a new study documenting the rapid recovery of fever and respiratory symptoms in COVID-19 patients at the University of Chicago Medicine Hospital.
Starbucks' new move is aimed at boosting the digital part of its business in China, one of its key markets. Starbucks has collaborated with the venture capital firm Sequoia Capital China to co-invest in development firms in the second largest economy in the world.
This week, as clinical trials on humans were approved in Germany and launched in the UK, the race to produce an effective vaccine against the novel coronavirus has gathered momentum. While about 150 research projects are now being implemented worldwide, the German and British plans are among only five human clinical trials approved worldwide.
The diagnostic authorization — developed by testing giant LabCorp — marks the first time the agency has cleared up a Covid-19 at-home test and ends weeks of back-and-forth between the agency and companies who have tried to produce their own versions of the tests that would allow at-home sampling.